Arman C. Moshyedi, MD, PLLC(a division of Greenbrook TMS NeuroHealth Centers Services, LLC)
SEEKING PART-TIME BOARD CERTIFIED & BOARD ELIGIBLE PSYCHIATRISTS FOR ON SITE TMS TREATMENT AND TO EXPAND SPRAVATO® PROGRAM IN ANN ARBOR, MI.
Greenbrook now operates 130 centers throughout the United States with a focus on specialized services for treatment-resistant depression, OCD, and other mental health disorders.
WHY JOIN?
Greenbrook is a leading provider of Transcranial Magnetic Stimulation (TMS) therapy, which administers local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Additionally, Greenbrook now offers the only FDA-approved ketamine-based psychedelic treatment for depression. Since inception, Greenbrook has provided more than 1.3 MILLION TMS treatments to over 40,000 patients struggling with depression.
Over 16 million Americans are affected by depression. Greenbrook TMS is changing the way that depression is treated, and YOU can be part of making a positive difference in the lives of patients by joining our amazing team!
To learn more about our WHY, click here: https://youtu.be/yrr-wlFftT0
For patient testimonies on HOW we are transforming lives for the better, click here: https://www.greenbrooktms.com/patient-stories
To access provider information, click here: https://www.greenbrookproviders.com
Greenbrook’s Ann Arbor center is Ann Arbor’s most-trusted provider for TMS (Transcranial Magnetic Stimulation) therapy and nasal esketamine. TMS therapy is FDA-cleared for the treatment of depression and Obsessive-Compulsive Disorder (OCD). Nasal esketamine is the only FDA-approved ketamine-based psychedelic treatment for depression. Both TMS therapy and nasal esketamine are available for you at our Ann Arbor center and covered by most insurance in Ann Arbor and throughout Michigan.
This site is only intended for job seekers to contact the organizations posting jobs. Use of this site for solicitation and other unintended purposes is prohibited.